Heterotrimeric G-proteins Activate Cl
Channels
through Stimulation of a Cyclooxygenase-dependent Pathway
in a Model Liver Cell Line*
Gordan
Kilic
and
J. Gregory
Fitz
From the Department of Medicine, University of Colorado Health
Sciences Center, Denver, Colorado 80262
Received for publication, September 7, 2001, and in revised form, January 3, 2002
 |
ABSTRACT |
Circulating hormones produce rapid changes in the
Cl
permeability of liver cells through activation
of plasma membrane receptors coupled to heterotrimeric G-proteins. The
resulting effects on intracellular pH, membrane potential, and
Cl
content are important contributors to the overall
metabolic response. Consequently, the purpose of these studies
was to evaluate the mechanisms responsible for G-protein-mediated
changes in membrane Cl
permeability using HTC
hepatoma cells as a model. Using patch clamp techniques,
intracellular dialysis with 0.3 mM guanosine 5'-O-(3-thiotriphosphate) (GTP
S) increased membrane
conductance from 10 to 260 picosiemens/picofarads due to activation of
Ca2+-dependent Cl
currents that
were outwardly rectifying and exhibited slow activation at depolarizing
potentials. These effects were mimicked by intracellular AlF
(0.03 mM) and
inhibited by pertussis toxin (PTX), consistent with current activation
through G
i. Studies using defined agonists and
inhibitors indicate that Cl
channel activation by GTP
S
occurs through an indomethacin-sensitive pathway involving sequential
activation of phospholipase C, mobilization of Ca2+ from
inositol 1,4,5-trisphosphate-sensitive stores, and stimulation of
phospholipase A2 and cyclooxygenase (COX). Accordingly, the conductance responses to GTP
S or to intracellular Ca2+
were inhibited by COX inhibitors. These results indicate that PTX-sensitive G-proteins regulate the Cl
permeability of
HTC cells through Ca2+-dependent stimulation of
COX activity. Thus, receptor-mediated activation of
G
i may be essential for hormonal regulation of liver
transport and metabolism through COX-dependent opening of a
distinct population of plasma membrane Cl
channels.
 |
INTRODUCTION |
Liver cells undergo rapid changes in the rate of transport of
ions, glucose, and bile acids in response to changing physiological demands (1, 2). Recent studies have emphasized a key role for plasma
membrane Cl
channels in this response (3-5). Under basal
conditions, membrane Cl
permeability is low. However,
increases in cell volume or hormonal stimulation increase membrane
Cl
permeability ~20-fold through opening of
Cl
channels in the plasma membrane. The resulting efflux
of Cl
is not only essential for regulation of cell volume
(5, 6) but also modulates a broad range of transport and metabolic
processes through effects on intracellular pH (7), membrane potential (8), and bile formation (6). Whereas definition of cellular mechanisms
involved in Cl
channel regulation represents an important
focus for modulating liver cell and organ function, little is known
about the specific channels and signaling pathways involved.
In previous studies, the biophysical properties of a volume-sensitive
Cl
current (ICl,swell) that functions to
maintain liver cell volume within a narrow physiological range have
been defined (4, 5, 9). Current activation depends on rapid
translocation of protein kinase C
to the plasma membrane, release of
ATP into the extracellular space, and autocrine activation of P2
purinergic receptors (3, 10). In addition, large increases in
Cl
conductance are observed after exposure to angiotensin
II and noradrenaline (11), hormones that bind to receptors coupled to
heterotrimeric G-proteins (8). However, it is not known whether these
hormone-activated Cl
channels are the same as those
involved in ICl,swell, and whether they are regulated by
distinct signaling pathways.
In liver cells and other epithelial cells, the mechanisms for
activation of different Cl
channels including the
ICl,swell are not known (12). It is well documented that
5-nitro-2-(3-phenylpropylamino)benzoic acid (NPPB)1 effectively inhibits
opening of different Cl
channels (12, 13). In addition to
its function as a Cl
channel blocker, NPPB is also a
potent inhibitor of the enzymatic activity of cyclooxygenase in a
manner analogous to indomethacin and aspirin (14). Cyclooxygenases are
present in liver cells and utilize arachidonic acid as a substrate to
generate prostaglandins that are known to modulate a broad range of
diverse physiological processes (15).
Based on these considerations, the purpose of these studies was to
evaluate the potential role of heterotrimeric G-proteins on the
Cl
conductance of a model liver cell line and the
specific signaling pathways involved. Using patch clamp techniques,
intracellular dialysis with GTP
S to activate heterotrimeric
G-proteins increased membrane permeability to Cl
by
~25-fold due to opening of plasma membrane Cl
channels.
The current was biophysically distinct from ICl,swell and
was mediated through a PTX-sensitive pathway that involves stimulation
of phospholipase C, subsequent release of Ca2+ from
endoplasmic reticulum, activation of phospholipase A2, and increases in cyclooxygenase activity. Thus, agonist binding to G
i-coupled receptors is closely associated with
activation of membrane Cl
channels through an
indomethacin-sensitive pathway, and the signaling pathways and channels
involved represent potential sites for pharmacological modulation of
liver cell transport and metabolism.
 |
EXPERIMENTAL PROCEDURES |
Cell Preparation--
All experiments were performed in HTC
cells derived from rat hepatoma using methods described previously (9,
16). These cells have been used widely as a stable model of hepatocyte
ion transport because they exhibit signaling pathways and ion channels analogous to those found in primary hepatocytes (4, 9, 17, 18). In
addition, HTC cells express insulin and other receptors that are linked
to heterotrimeric G-proteins (9, 19). Cells were plated on coverslips
and maintained at 37 °C in a 5% CO2 and 95% air
atmosphere in culture media composed of minimal essential medium
(Invitrogen) supplemented with 5% fetal calf serum, 2 mM L-glutamine, 100 IU/ml penicillin, and 100 µg/ml streptomycin.
Solutions for Electrophysiological Studies--
Before study,
coverslips containing cells were removed from culture media and placed
in an extracellular solution that contained 142 mM NaCl, 4 mM KCl, 1 mM KH2PO4, 2 mM MgCl2, 2 mM CaCl2,
10 mM D-glucose, and 10 mM HEPES/NaOH. For
patch clamp recordings, cells were dialyzed with different pipette
solutions as indicated. The standard pipette solution contained 130 mM KCl, 10 mM NaCl, 1 mM EGTA, 0.5 mM CaCl2, 2 mM MgCl2,
and 10 mM HEPES/NaOH (free [Ca2+] = ~0.1
µM). In some experiments to move Cl
equilibrium potential to about
40 mV, intracellular
[Cl
] was decreased by dialysis with a low
Cl
solution that contained 130 mM
K-glutamate, 20 mM NaCl, 1 mM EGTA, 0.5 mM CaCl2, 2 mM MgCl2,
and 10 mM HEPES/NaOH. To buffer [Ca2+]i to lower levels, cells were dialyzed with
a solution that contained 125 mM KCl, 10 mM
NaCl, 5 mM EGTA, 2 mM MgCl2, and 10 mM HEPES/NaOH. The activity of endogenous G-proteins was increased by adding the nonhydrolyzable GTP analog GTP
S (0.3 mM) to the different pipette solutions. To stimulate
heterotrimeric G-proteins more specifically, cells were dialyzed with
an aluminum fluoride solution that contained 120 mM KCl, 10 mM NaCl, 10 mM NaF, 0.03 mM
AlCl3, 1 mM EGTA, 0.5 mM
CaCl2, 2 mM MgCl2, and 10 mM HEPES/NaOH. Under these conditions, the concentration of
AlF
was 30 µM (20). To
buffer [Ca2+]i to 1 µM, cells were
dialyzed with a solution that contained 125 mM
cesium-D-glutamate, 10 mM NaCl, 5 mM EGTA, 4.45 mM CaCl2, 2 mM MgCl2, and 10 mM HEPES/CsOH.
This solution contained low [Cl
] and high
[Cs+] to block Ca2+-activated K+
channels in HTC cells. The free [Ca2+]i was
determined as described previously (21). The pH of all solutions was
7.25. Osmolarity of the extracellular solution was 300 mosmol/kg, and the osmolarity of the pipette solutions was
270-275 mosmol/kg. All compounds were purchased from Sigma.
Conductance and Current Measurements--
Using patch clamp
techniques, plasma membrane conductance was measured in the whole-cell
recording configuration. Cells were voltage-clamped at
40 mV, and
membrane conductance was determined every 3 s by applying 4-ms
voltage pulses (pulse amplitude, 40 mV). The current response was used
to determine the conductance and the capacitance as described
previously (22). To compare GTP
S-activated conductance responses
from different cells, the conductance was normalized to the initial
capacitance (measure of cell surface area) and expressed in pS/pF.
Whole-cell currents were measured in response to intracellular GTP
S,
after membrane capacitance and access resistance were compensated.
Whole-cell currents in response to voltage pulses were filtered with an
8-pole Bessel filter at a 1 kHz cut-off frequency and sampled every 0.5 ms. To determine reversal potential, a voltage ramp from
90 mV to 90 mV (duration, 0.2 s) was applied. Reversal potentials were
determined taking into account the corrections for liquid junction
potentials. With standard external solution and low Cl
pipette solutions, the liquid junction potential was measured to be 5 mV.
Detection of PLA2 Activity--
The activity of
phospholipase A2 was monitored using an engineered
phospholipid molecule, PED6 (Molecular Probes), as described previously
(23). PED6 is a substrate for PLA2 and consists of a
phospholipid labeled with a fluorescent molecule (BODIPY) and a
quencher molecule (dinitrophenyl). PED6 is nonfluorescent in the
solution but becomes fluorescent after removal of dinitrophenyl by
activated PLA2. Consequently, the fluorescence intensity of cleaved PED6 is a direct measure of PLA2 activity (23,
24).
Before the experiments, cells were incubated with PED6 (0.3 µg/ml)
for 2 h and then washed to remove PED6 from extracellular media.
The intracellular PED6 fluorescence was monitored using an oil
immersion Olympus objective ×60 (NA = 1.2) and a SensicamQE camera controlled by SlideBook 3.0 software (Intelligent Imaging Innovations). Images were acquired every 30 s from regions
containing cells. Background fluorescence was determined from regions
containing no cells and was subtracted from the cell fluorescence. All
fluorescence data were analyzed using IgorPro 3.14 software (Wavemetrics).
Cell Treatments--
To evaluate the role of pertussis
toxin-sensitive heterotrimeric G-proteins on the GTP
S-evoked
conductance, cells were incubated overnight with pertusiss toxin (200 ng/ml) from Bordetella pertussis. The potential involvement
of PLC was assessed by including neomycin sulfate or spermine
(inhibitors of PLC) with GTP
S in the standard pipette solution. The
involvement of arachidonic acid in GTP
S response was assessed in two
manners: different concentrations of arachidonic acid were included in
the standard pipette solution, or cells were exposed directly to
arachidonic acid in the extracellular solution. The potential role of
cyclooxygenase (COX) was assessed in similar manners. Cells were
exposed to the COX inhibitor NPPB (20 µM), or
indomethacin (10 µM) or aspirin (100 µM)
was included in the standard pipette solution together with GTP
S or
1 µM [Ca2+]i. These reagents were
purchased from Calbiochem.
All experiments were performed at 24 °C. Data are expressed as the
means ± S.E. Results were compared using Student's t
test on paired or unpaired data.
 |
RESULTS |
To evaluate whether GTP-binding proteins are capable of regulating
the plasma membrane conductance of HTC cells, the cell interior was
dialyzed with GTP
S (0.3 mM) through a patch pipette while measuring whole-cell conductance. GTP
S is a nonhydrolyzable GTP analog that increases the activity of a broad range of
GTP-dependent proteins. Representative recordings of
normalized conductance (pS/pF) from cells dialyzed with (top
trace) and without (bottom trace) GTP
S are shown in
Fig. 1A. Under control
conditions, membrane conductance was small and remained stable during
recordings. Intracellular GTP
S stimulated a large
increase in conductance that reached maximal values within ~2 min and
then slowly decreased over time. In 12 of 18 cells dialyzed with
GTP
S, multiple transient increases in conductance were observed
(Fig. 1A). The peak conductance of the first transient was
always the largest and was taken for analysis. In Fig.
1B, the peak conductance of cells dialyzed with or
without GTP
S is shown. These findings indicate that intracellular
GTP
S leads to a ~ 25-fold increase in the membrane
conductance of HTC cells.

View larger version (14K):
[in this window]
[in a new window]
|
Fig. 1.
Intracellular GTP S
activates membrane conductance in HTC cells. A,
whole-cell conductance was measured in cells dialyzed with standard
pipette solution in the presence (top trace) or absence
(bottom trace) of GTP S (0.3 mM).
Intracellular dialysis with GTP S resulted in activation of a
conductance that exhibited multiple transients. For comparison, the
conductance was normalized to the cell surface area. Dashed
lines indicate initial conductance level after achieving the
whole-cell configuration. Holding potential was 40 mV.
B, the normalized peak conductance from cells dialyzed
with (18 cells) or without GTP S (4 cells).
|
|
To characterize the properties of the GTP
S-activated conductance,
current-voltage relations were measured in solutions of differing ionic
composition. The dominant response, observed in 8 of 11 cells, is
illustrated in Fig. 2A. With
standard pipette solution, currents reversed near the Cl
equilibrium potential of 0 mV, were outwardly rectifying, and exhibited
slow activation at depolarizing potentials above 10 mV. In the
remaining 3 of 11 cells, currents also reversed near 0 mV and were
outwardly rectifying but showed slow inactivation at depolarizing
potentials, properties suggestive of the ICl,swell, the
Cl
current activated by volume increase of HTC cells (4,
10). The reversal potential of all GTP
S-evoked currents was
3.0 ± 2.1 mV (Fig. 2B, 14 cells). Decreasing
intracellular [Cl
] from 145 to 25 mM
shifted the reversal potential of currents to
39.7 ± 5.4 mV
(Fig. 2B, 10 cells), close to the new Cl
equilibrium potential. These findings indicate that the
GTP
S-stimulated conductance is due to opening of Cl
channels, and the dominant response involves an outwardly rectifying conductance that shows slow activation at depolarizing potentials.

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 2.
Whole-cell currents evoked by
GTP S are permeable to Cl
ions. A, the properties of the GTP S (0.3 mM)-activated whole-cell currents were evaluated using
voltage steps as indicated at the top right (voltage pulses
were 0.5 s in duration). Holding potential was 40 mV.
Dashed line indicates the level of zero current. Currents
were outwardly rectifying and showed slow activation at test potential
above 10 mV. B, whole-cell currents were measured in
the presence of GTP S in response to voltage ramps from 90 mV to 90 mV (duration, 0.2 s). With standard pipette solution, the
GTP S-activated current reversed near 0 mV, close to the
Cl equilibrium potential (thick line). In a
cell dialyzed with low Cl solutions, the reversal
potential shifted to more negative potentials (thin line),
as anticipated for activation of a Cl -selective
conductance.
|
|
In many cells, intracellular GTP
S has been shown to activate
ICl,swell (25-28). In HTC cells, activation of
ICl,swell is mediated by an autocrine mechanism that is
mediated by release of ATP into extracellular space and activation of
purinergic receptors (10). To assess whether GTP
S stimulates opening
of Cl
channels through ATP release, cells were exposed to
apyrase, an enzyme that rapidly hydrolyzes ATP and completely inhibits opening of ICl,swell in HTC cells (10). A representative
recording is shown in Fig. 3. The
presence of apyrase to eliminate extracellular ATP had no effect on the
response to GTP
S because the peak of GTP
S-activated conductance
in the presence of apyrase (227 ± 37 pS/pF; 5 cells) was not
significantly different from the values measured in the absence of
apyrase (261 ± 38 pS/pF; 18 cells; p > 0.30).
Thus, intracellular GTP
S activates Cl
channels in HTC
cells through a mechanism different from ATP release.

View larger version (6K):
[in this window]
[in a new window]
|
Fig. 3.
Hydrolysis of extracellular ATP does not
inhibit GTP S-activated conductance in HTC
cells. Normalized conductance was measured in cells dialyzed with
GTP S (0.3 mM) in the absence (left) or
presence (right) of extracellular apyrase (2 units/ml).
Apyrase hydrolyzes ATP, prevents activation of purinergic receptors,
and inhibits ICl,swell in HTC cells. Dashed
lines indicate the initial conductance level after the break-in.
Note that apyrase did not prevent activation of membrane conductance by
GTP S.
|
|
The conductance response to GTP
S could result from activation of
heterotrimeric G-proteins (29) or inactivation of certain small
monomeric GTP-binding proteins (30, 31). To distinguish between these
possibilities, cells were dialyzed with a pipette solution that
contained aluminum fluoride instead of GTP
S.
AlF
is thought to permanently
activate heterotrimeric G-proteins (29) but to have no effect on
monomeric GTP-binding proteins (32). A representative recording is
shown in Fig. 4A. Similar to
GTP
S, AlF
(30 µM)
stimulated multiple transient increases in conductance that inactivated
over several minutes. Moreover, the reversal potential of
AlF
-activated currents was close
to Cl
equilibrium potential, and currents were outwardly
rectifying (Fig. 4B). However, the peak of
AlF
-activated conductance was
455 ± 97 pS/pF (5 cells), significantly larger than the peak of
GTP
S-activated response (p > 0.05). These
observations demonstrate that selective activation of heterotrimeric
G-proteins by AlF
mimics the response
to intracellular GTP
S in HTC cells.

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 4.
AlF and
noradrenaline activate whereas PTX inhibits Cl
conductance in HTC cells. A, representative normalized
conductances from cells dialyzed with a fluoride solution (30 µM AlF , left
trace) or GTP S (0.3 mM, right traces).
AlF activated currents analogous to
those activated by GTP S. The response to GTP S was inhibited by
overnight incubation with PTX (200 ng/ml). Dashed lines
indicate initial conductance level after the break-in.
B, current response of
AlF -evoked conductance to a voltage
ramp (from 90 mV to 90 mV, 0.2 s in duration). Note that the
current is outwardly rectifying with reversal potential close to 0 mV.
C, exposure to noradrenaline (1 µM;
NA) to stimulate receptor-dependent
activation of G i activated whole-cell currents with
analogous properties. Voltage protocol was as defined in Fig.
2A.
|
|
Heterotrimeric G-proteins that are sensitive to PTX are essential for
the response of liver cells to many hormones (33-35). To test whether
the heterotrimeric G-proteins activated by GTP
S are PTX-sensitive,
cells were incubated overnight in the presence of PTX. Pretreatment
with PTX substantially decreased the response to GTP
S (Fig.
4A), decreasing the magnitude of the GTP
S-activated conductance to 86 ± 11 pS/pF (4 cells; p < 0.05). Finally, whole-cell currents were measured after exposure to
noradrenaline (1 µM), a physiological agonist that
activates receptors coupled to G
i. A representative
recording is shown in Fig. 4C. Noradrenaline activated
currents (4 cells) analogous to those stimulated by GTP
S, with
properties including slow activation at depolarizing potentials,
outward rectification, and reversal potential close to Cl
equilibrium potential (data not shown). Taken together, these findings
suggest that the response to GTP
S is mediated in large part by
activation of pertussis toxin-sensitive G-proteins of the
G
i family.
In liver cells, stimulation of G
i could open
Cl
channels directly through G-protein-channel
interactions or indirectly through activation of intermediary signaling
pathways. One pathway that has been linked to PTX-sensitive G-proteins
in liver involves stimulation of phospholipase C and subsequent
mobilization of Ca2+ through inositol 1,4,5-trisphosphate
(IP3)-sensitive channels in the endoplasmic reticulum (ER)
(36). To test this possibility, cells were treated with neomycin (1 mM) or spermine (1 mM) to inhibit PLC. Each
inhibitor decreased the amplitude of the GTP
S-stimulated conductance
response by ~ 80% (Fig. 5).
Similarly, intracellular dialysis with heparin, a blocker of
IP3-sensitive channels (37), or buffering of
[Ca2+]i to low levels by dialysis with a pipette
solution containing 5 mM EGTA substantially inhibited the
response to GTP
S (Fig. 5). These observations suggest that the
response to GTP
S is mediated in large part by effects of
G
i on PLC, leading to release of Ca2+
from intracellular stores.

View larger version (11K):
[in this window]
[in a new window]
|
Fig. 5.
Conductance response to
GTP S requires activation of PLC and release of
Ca2+ from IP3-sensitive intracellular
stores. The normalized peak conductance was measured in whole-cell
configuration from HTC cells dialyzed with a standard pipette solution
that contained 0.3 mM GTP S (18 cells). Inclusion of a
PLC inhibitor (neomycin (4 cells) or spermine (5 cells); 1 mM for both treatments) in the intracellular solution
markedly decreased the peak conductance (p < 0.02).
Similarly, the presence of heparin to block IP3-sensitive
channels (1 mg/ml; 4 cells; p < 0.04) or strong
Ca2+ buffering with 5 mM EGTA (4 cells;
p < 0.02) in the standard pipette solution prevented
activation of the conductance by GTP S.
|
|
The release of Ca2+ from ER is essential for the response
of liver cells to different hormones (8, 11, 35). To test whether intracellular Ca2+ is capable of activating membrane
conductance without participation of heterotrimeric G-proteins, cells
were treated with thapsigargin (20 µM), an inhibitor of
intracellular Ca2+-ATPase that causes release of
Ca2+ from the endoplasmic reticulum of hepatocytes (38). As
shown in Fig. 6A, exposure to
thapsigargin activated Cl
-selective currents with
properties of those activated by GTP
S (5 cells). These data indicate
that the release of Ca2+ from endoplasmic reticulum
per se is capable of activating Cl
conductance
in HTC cells.

View larger version (29K):
[in this window]
[in a new window]
|
Fig. 6.
Release of Ca2+ from the ER
stimulates Cl currents and increases the activity of
PLA2. A, whole-cell currents were
measured after exposure to thapsigargin (20 µM;
TG) using the voltage protocol defined in Fig. 2. Note
that currents demonstrated outward rectification and slow activation at
depolarizing potentials (5 cells). B, intracellular
fluorescence was measured in cells loaded with PED6, a reporter
molecule sensitive to changes in PLA2 activity. Exposure to
thapsigargin (20 µM; arrow) was followed by
multiple transient increases in cellular fluorescence. C,
fluorescence images of the cell shown in B obtained before
(1) and after (2) exposure to thapsigargin.
Fluorescence of PED6 appears to be distributed throughout the cytosol
and not in nucleus, with several localized regions of increased
PLA2 activity. Scale bar, 5 µm.
|
|
In liver, PTX-sensitive G
i and increases in
intracellular [Ca2+] lead to the activation of a
Ca2+-dependent PLA2, resulting in
generation of arachidonic acid (39). To evaluate whether this mechanism
is operative in HTC cells, the activity of PLA2 was
monitored by measuring PED6 fluorescence (24) as shown in Fig. 6,
B and C. After loading with PED6, cells were
placed in dye-free solution, and intracellular fluorescence was
measured in the absence or presence of thapsigargin. In the absence of
thapsigargin, cells had a low level of baseline fluorescence likely
resulting from basal PLA2 activity. Fluorescence intensity gradually decreased over time as the PLA2-cleaved
fluorescent dye slowly diffused out of the cell interior (11 cells).
Interestingly, exposure to thapsigargin to increase
[Ca2+]i markedly increased PED6 fluorescence
(Fig. 6C, 6 cells). In 4 of 6 cells, the fluorescence
pattern showed multiple transients that decayed slowly after reaching a
peak, similar to the pattern observed with the conductance response to
GTP
S. These results suggest that in HTC cells, mobilization of
Ca2+ from the ER leads to rapid activation of
Ca2+-dependent PLA2.
Ca2+-dependent activation of PLA2
would be anticipated to increase local concentrations of arachidonic
acid (AA) (40), which serves as a substrate for generation of
prostaglandins by cyclooxygenase (41). To test whether AA per
se is capable of activating membrane conductance, cells were
treated with increasing concentrations of AA (1-25 µM).
Under basal conditions, with the standard pipette solution containing
0.1 µM [Ca2+]i, arachidonic acid
had minimal effects on membrane conductance (Fig.
7). To assess the alternative possibility
that the GTP
S-activated conductance requires stimulation of COX
activity and generation of prostaglandins from AA, the effects of
putative inhibitors of COX on the response to GTP
S were evaluated.
NPPB is an effective blocker of Cl
channels in HTC cells
(4), and it may function either by direct effects on the open channel
configuration or indirectly through inhibition of COX activity (14).
Exposure of cells to NPPB when GTP
S-evoked currents were already
maximal had no immediate effect on the conductance (3 cells; data not
shown), indicating that NPPB is not likely to act directly on the open
channel configuration. However, pretreatment of liver cells with NPPB
for several minutes before GTP
S dialysis inhibited the conductance
by ~90% (Fig. 7). Similarly, the GTP
S-stimulated Cl
conductance was also blocked by indomethacin or aspirin, potent inhibitors of COX activity (Fig. 7).

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 7.
Effects of arachidonic acid and COX
inhibitors on membrane conductance in HTC cells. Normalized peak
conductance was measured in whole-cell configuration after different
treatments. Cells were either dialyzed or exposed to different
micromolar concentrations of arachidonic acid. Note that with the
standard pipette solution ([Ca2+]i = ~0.1
µM), arachidonic acid had only small effects on
conductance. Inhibition of COX by treatment with NPPB (20 µM; 5 cells), indomethacin (10 µM; 5 cells), or aspirin (100 µM; 4 cells) markedly decreased
the conductance response to GTP S (p < 0.02 for each
inhibitor).
|
|
These findings suggest that GTP
S, by increasing
[Ca2+]i, may regulate Cl
permeability indirectly through a cyclooxygenase-dependent
pathway. To test this possibility more directly, additional studies
were performed in cells dialyzed with a pipette solution that contained 1 µM [Ca2+]i in the absence or
presence of the COX inhibitor indomethacin. A representative recording
is shown in Fig. 8A. Increases
in [Ca2+]i activated currents with biophysical
properties analogous to those activated by GTP
S or thapsigargin,
including slow activation and outward rectification at depolarizing
potentials (Fig. 8, A and B, 7 cells).
Unlike GTP
S-activated currents, Ca2+-activated currents
did not inactivate during several minutes of recording (Fig.
8C). With low [Cl
] in the intracellular
solution (25 mM), the reversal potential of these currents
was
42.8 ± 1.8 mV (Fig. 8B, 5 cells), close to
a Cl
equilibrium potential. Notably, treatment with
indomethacin prevented activation of currents by Ca2+ (Fig.
8, C and D, 6 cells). These results suggest
that intracellular Ca2+ is not likely to regulate
Cl
channels directly. It is more likely that
GTP
S stimulates a signaling pathway that involves activation
of G
i, subsequent mobilization of Ca2+ from
the ER, activation of Ca2+-dependent
PLA2, and stimulation of COX activity (Fig.
9). Thus, the prostaglandin products of
COX are likely to represent signaling molecules that mediate changes in
the Cl
permeability of HTC cells due to the activation of
hormone receptors coupled to heterotrimeric G-proteins.

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 8.
Intracellular Ca2+ activates
Cl channels through an indomethacin-sensitive
pathway. A, whole-cell currents were measured in
cells dialyzed with a pipette solution that contained 1 µM [Ca2+]. Pulse potentials are the same as
those indicated in Fig. 2. B, response of
Ca2+-activated currents to voltage ramp (from 90 mV to 90 mV, 0.2 s in duration). With the low Cl pipette
solution, Ca2+-activated currents reversed near the
Cl equilibrium potential and demonstrated slow activation
at depolarizing potentials. C, representative
conductance recordings are shown from cells dialyzed with 1 µM [Ca2+] containing solution in the
absence (top trace) or presence (bottom trace) of
indomethacin (10 µM). D, normalized peak
conductance response of Ca2+-activated channels in the
absence (5 cells) or presence of indomethacin (6 cells;
p < 0.04).
|
|

View larger version (11K):
[in this window]
[in a new window]
|
Fig. 9.
Proposed model for
GTP S-dependent activation of
Cl currents. These findings suggest the presence of
a signaling cascade regulated by PTX-sensitive G i that
involves sequential activation of PLC, mobilization of Ca2+
through IP3-sensitive channels in the ER, stimulation of
PLA2 to cleave AA from membrane phospholipids, and
generation of COX products (prostaglandins (PG)) that
mediate changes in Cl channel open probability.
|
|
 |
DISCUSSION |
Liver cell transport and metabolism are closely regulated by
circulating hormones in response to changing physiological demands. The
principal findings of these studies of a model liver cell line suggest
that receptors coupled to PTX-sensitive G-proteins (G
i)
modulate membrane Cl
permeability through a sequence of
events involving activation of phospholipase C, mobilization of
Ca2+ from IP3-sensitive stores, activation of
phospholipase A2, and generation of cyclooxygenase products
that mediates changes in channel open probability. Accordingly,
intracellular Ca2+ does not appear to regulate these
channels directly but activates an indomethacin-sensitive conductance
that is biophysically distinct from that activated by increases in cell
volume. Consequently, this represents a candidate for the
Cl
conductance activated by multiple
G
i-coupled receptors in hepatocytes and a potential
target for modulating liver metabolic functions through effects on
membrane Cl
permeability.
Intracellular application of GTP
S has been utilized as a nonspecific
probe to assess the effects of G-proteins on membrane permeability. In
endothelial cells (25), pigmented ciliary epithelial cells (28), and
adrenal chromaffin cells (26, 27), GTP
S activates Cl
currents that closely resemble the volume-activated conductance ICl,swell. Because HTC cells express the
ICl,swell at high density (4, 10), activation of
ICl,swell by GTP
S was anticipated. Instead, the dominant
conductance exhibited properties more compatible with a
Ca2+-activated Cl
conductance
(ICl(Ca)), including outward rectification and slow activation at depolarizing potentials. The ICl(Ca) was also
observed after increasing [Ca2+]i in secretory
epithelia (42-45), smooth muscle cells (46), and adipocytes (47).
Whereas in these cells the ICl(Ca) has roles in fluid
secretion and response to neurotransmitters, the physiological roles of
this current in liver cells are not readily apparent. However, even
small changes in membrane Cl
permeability influence the
membrane potential of hepatocytes, which plays an essential role in
regulation of gluconeogenesis (48) as well as uptake of bile acids,
amino acids, and HCO
(49, 50). In that light,
it is intriguing that receptors for insulin (33), vasopressin (35),
epidermal growth factor (36), and possibly other agonists signal in
part via PTX-sensitive G-proteins. Moreover, analogous currents are
detected in HTC cells after exposure to both insulin (51) and
noradrenaline (Fig. 4). Consequently, it is attractive to speculate
that opening of ICl(Ca) represents an important regulatory
event for these agonists.
In liver (36) and other cell types (52-54), PTX-sensitive G-proteins
activate PLC and lead to increases in
[Ca2+]i due to Ca2+
mobilization from IP3-sensitive stores (8, 11). These
general conclusions regarding initiation of signaling via
G
i and Ca2+ mobilization are supported by
three primary observations. First, intracellular
AlF
, a more specific activator of
heterotrimeric G-proteins, stimulated currents indistinguishable from
those activated by GTP
S (Fig. 4A). Second, pretreatment with PTX to down-regulate G
i markedly inhibited the
current response (Fig. 4B). Finally, inhibition of PLC or
blockade of IP3-sensitive Ca2+ release
prevented current activation by GTP
S. Notably, increases in
[Ca2+]i stimulated by thapsigargin or dialysis
with Ca2+-containing pipette solutions activated the same
current in the nominal absence of changes in G
i
activity. Because the responses to increased
[Ca2+]i or GTP
S were inhibited by indomethacin
and other inhibitors of cyclooxygenase, these findings suggest the
presence of important functional interactions between PLC- and
COX-dependent signaling pathways in liver cells.
These interactions appear to be mediated in part by
Ca2+-dependent stimulation of PLA2
as detected by the effects of thapsigargin on the fluorescence of cells
loaded with the PLA2 substrate PED6. The resulting increase
in arachidonic acid production does not appear to regulate
Cl
channels directly because cell treatments with
arachidonic acid under basal [Ca2+]i (~0.1
µM) failed to activate currents. This differs from some
cell types in which exposure to arachidonic acid results in increased
biological effects of prostaglandins, indicating that basal COX
activity is capable of synthesizing prostaglandins (55, 56). However,
arachidonic acid represents the only known substrate for COX
(40), implying that Ca2+ mobilization either directly (Fig.
9) or through other signaling events increases COX activity in HTC
cells, leading to generation of prostaglandins. This putative sequence
is further supported by the observation that ICl(Ca)
activated by intracellular dialysis with 1 µM
[Ca2+] is largely prevented by indomethacin. Moreover,
these findings are consistent with reports in other cell types that
PLA2 activity and concomitant release of arachidonic acid
are closely regulated by [Ca2+]i (57).
Furthermore, because COX proteins are predominantly localized in the ER
(58), and the production of prostaglandins depends on
[Ca2+]i (59), it is likely that high
[Ca2+] produced at the outer leaflet of the ER after
activation of IP3-sensitive channels may influence the
generation of prostaglandins.
Assuming that these findings are relevant to liver cells in
vivo, three additional points merit further clarification. First, the potential relationship between ICl(Ca) and
ICl,swell is not fully defined. Whereas the most direct
interpretation of these findings is that different channels are
involved, the molecular identity of these Cl
channels is
not known, and GTP
S also activated currents with properties of
ICl,swell in a minority (~25%) of cells. Consequently, it is possible that GTP
S stimulates more than one signaling pathway and that a single channel protein could exhibit different properties according to the dominant signaling pathway involved. In HTC cells, CLC-2 chloride channel proteins appear to contribute to cell volume regulation, but mRNA for CLC-3, CLC-6, and CLC-7 is also expressed (5). Ultimately, it will be important to link these molecular candidates with specific physiological functions in liver cells. Second, whereas it is clear that COX products of arachidonic acid are
necessary for channel activation, it is not clear which prostaglandins are involved. Moreover, the mechanistic links between Ca2+
mobilization and COX activation are not defined. Also, it is not
apparent which COX isoforms are involved in channel activation. Third,
whereas hepatocytes produce small amounts of prostaglandins under basal
conditions (60), a dramatic increase in production is observed in
regenerating hepatocytes after partial liver removal (61).
Consequently, it is attractive to speculate that
prostaglandin-dependent regulation of membrane
Cl
permeability could have broader roles in other liver
functions as well. Whereas prostaglandins have been implicated in the
regulation of hepatocyte glycogenolysis (62) and oxygen consumption
(63), it is not clear whether the actions of prostaglandins are
mediated by direct effects on channel proteins or activation of
specific receptors.
In summary, these findings suggest the presence of a signaling cascade
regulated by PTX-sensitive G
i that involves sequential activation of phospholipase C, Ca2+ mobilization from
IP3-sensitive stores, activation of phospholipase A2, and generation of cyclooxygenase products that mediate
changes in channel open probability. Because the Cl
channels involved are biophysically distinct from those activated by
cell volume, they represent a candidate for the Cl
conductance activated by multiple G-protein-coupled receptors in
hepatocytes and a potential target for modulating liver metabolic functions through effects on membrane Cl
permeability.
 |
FOOTNOTES |
*
This work was supported by National Institutes of Health
Grants DK43278 and DK46082 (to J. G. F.), the Waterman Foundation (J. G. F.), and an American Liver Scholar Award (to G. K.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Dept. of Medicine,
University of Colorado Health Sciences Center, Campus Box B158, Rm.
6416, 4200 E. 9th Ave., Denver, CO 80262. Tel.: 303-315-4010; Fax:
303-315-5711; E-mail: gordan.kilic@uchsc.edu.
Published, JBC Papers in Press, January 25, 2002, DOI 10.1074/jbc.M108631200
 |
ABBREVIATIONS |
The abbreviations used are:
NPPB, 5-nitro-2-(3-phenylpropylamino)-benzoic acid;
AA, arachidonic acid;
PLC, phospholipase C;
COX, cyclooxygenase;
PTX, pertussis toxin;
GTP
S, guanosine 5'-O-(3-thiotriphosphate);
pS, picosiemens;
pF, picofarad;
PLA2, phospholipase
A2;
IP3, inositol 1,4,5-trisphosphate;
ER, endoplasmic reticulum.
 |
REFERENCES |
| 1.
|
Graf, J.,
and Haussinger, D.
(1996)
J. Hepatol.
24 Suppl. 1,
53-77[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Boyer, J. L.,
Graf, J.,
and Meier, P. J.
(1992)
Annu. Rev. Physiol.
54,
415-438[Medline]
[Order article via Infotrieve]
|
| 3.
|
Roman, R. M.,
Bodily, K. O.,
Wang, Y.,
Raymond, J. R.,
and Fitz, J. G.
(1998)
Hepatology
28,
1073-1080[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Bodily, K.,
Wang, Y.,
Roman, R.,
Sostman, A.,
and Fitz, J. G.
(1997)
Hepatology
25,
403-410[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Roman, R. M.,
Smith, R. L.,
Feranchak, A. P.,
Clayton, G. H.,
Doctor, R. B.,
and Fitz, J. G.
(2001)
Am. J. Physiol. Gastrointest. Liver Physiol.
280,
G344-G353[Abstract/Free Full Text]
|
| 6.
|
Haddad, P.,
Beck, J. S.,
Boyer, J. L.,
and Graf, J.
(1991)
Am. J. Physiol.
261,
G340-G348[Medline]
[Order article via Infotrieve]
|
| 7.
|
Gleeson, D.,
Corasanti, J. G.,
and Boyer, J. L.
(1990)
Am. J. Physiol.
258,
G299-G307[Medline]
[Order article via Infotrieve]
|
| 8.
|
Capiod, T.,
and Ogden, D. C.
(1989)
Proc. R. Soc. Lond. B Biol. Sci.
236,
187-201[Medline]
[Order article via Infotrieve]
|
| 9.
|
Fitz, J. G.,
and Sostman, A. H.
(1994)
Am. J. Physiol.
266,
G544-G553[Medline]
[Order article via Infotrieve]
|
| 10.
|
Wang, Y.,
Roman, R.,
Lidofsky, S. D.,
and Fitz, J. G.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
12020-12025[Abstract/Free Full Text]
|
| 11.
|
Ogden, D. C.,
Capiod, T.,
Walker, J. W.,
and Trentham, D. R.
(1990)
J. Physiol. (Lond.)
422,
585-602[Abstract/Free Full Text]
|
| 12.
|
Begenisich, T.,
and Melvin, J. E.
(1998)
J. Membr. Biol.
163,
77-85[CrossRef][Medline]
[Order article via Infotrieve]
|
| 13.
|
Strange, K.,
Emma, F.,
and Jackson, P. S.
(1996)
Am. J. Physiol.
270,
C711-C730[Medline]
[Order article via Infotrieve]
|
| 14.
|
Breuer, W.,
and Skorecki, K. L.
(1989)
Biochem. Biophys. Res. Commun.
163,
398-405[CrossRef][Medline]
[Order article via Infotrieve]
|
| 15.
|
Dubois, R. N.,
Abramson, S. B.,
Crofford, L.,
Gupta, R. A.,
Simon, L. S.,
Van De Putte, L. B.,
and Lipsky, P. E.
(1998)
FASEB J.
12,
1063-1073[Abstract/Free Full Text]
|
| 16.
|
Barnard, G. F.,
Erickson, S. K.,
and Cooper, A. D.
(1984)
J. Clin. Invest.
74,
173-184[Medline]
[Order article via Infotrieve]
|
| 17.
|
Heaton, J. H.,
Krett, N. L.,
Alvarez, J. M.,
Gelehrter, T. D.,
Romanus, J. A.,
and Rechler, M. M.
(1984)
J. Biol. Chem.
259,
2396-2402[Abstract/Free Full Text]
|
| 18.
|
Sung, C. K.,
and Goldfine, I. D.
(1992)
Biochem. Biophys. Res. Commun.
189,
1024-1030[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Sanchez-Margalet, V.
(1999)
Diabetologia
42,
317-325[CrossRef][Medline]
[Order article via Infotrieve]
|
| 20.
|
Hess, S. D.,
Doroshenko, P. A.,
and Augustine, G. J.
(1993)
Science
259,
1169-1172[Abstract/Free Full Text]
|
| 21.
|
Kilic, G.,
Angleson, J. K.,
Cochilla, A. J.,
Nussinovitch, I.,
and Betz, W. J.
(2001)
J. Physiol. (Lond.)
532,
771-783[Abstract/Free Full Text]
|
| 22.
|
Lindau, M.,
and Neher, E.
(1988)
Pflugers Arch.
411,
137-146[CrossRef][Medline]
[Order article via Infotrieve]
|
| 23.
|
Farber, S. A.,
Olson, E. S.,
Clark, J. D.,
and Halpern, M. E.
(1999)
J. Biol. Chem.
274,
19338-19346[Abstract/Free Full Text]
|
| 24.
|
Farber, S. A.,
Pack, M., Ho, S. Y.,
Johnson, I. D.,
Wagner, D. S.,
Dosch, R.,
Mullins, M. C.,
Hendrickson, H. S.,
Hendrickson, E. K.,
and Halpern, M. E.
(2001)
Science
292,
1385-1388[Abstract/Free Full Text]
|
| 25.
|
Voets, T.,
Manolopoulos, V.,
Eggermont, J.,
Ellory, C.,
Droogmans, G.,
and Nilius, B.
(1998)
J. Physiol. (Lond.)
506,
341-352[Abstract/Free Full Text]
|
| 26.
|
Doroshenko, P.,
and Neher, E.
(1992)
J. Physiol. (Lond.)
449,
197-218[Abstract/Free Full Text]
|
| 27.
|
Doroshenko, P.,
Penner, R.,
and Neher, E.
(1991)
J. Physiol. (Lond.)
436,
711-724[Abstract/Free Full Text]
|
| 28.
|
Mitchell, C. H.,
Zhang, J. J.,
Wang, L.,
and Jacob, T. J.
(1997)
Am. J. Physiol.
272,
C212-C222[Medline]
[Order article via Infotrieve]
|
| 29.
|
Gilman, A. G.
(1987)
Annu. Rev. Biochem.
56,
615-649[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Takel, K.,
McPherson, P. S.,
Schmid, S. L.,
and De Camilli, P.
(1995)
Nature
374,
186-190[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
Johannes, L.,
Lledo, P. M.,
Roa, M.,
Vincent, J. D.,
Henry, J. P.,
and Darchen, F.
(1994)
EMBO J.
13,
2029-2037[Medline]
[Order article via Infotrieve]
|
| 32.
|
Kahn, R. A.
(1991)
J. Biol. Chem.
266,
15595-15597[Abstract/Free Full Text]
|
| 33.
|
Sanchez-Margalet, V.,
Gonzalez-Yanes, C.,
Santos-Alvarez, J.,
and Najib, S.
(1999)
Cell Mol. Life Sci.
55,
142-147[CrossRef][Medline]
[Order article via Infotrieve]
|
| 34.
|
Berven, L. A.,
and Barritt, G. J.
(1994)
FEBS Lett.
346,
235-240[CrossRef][Medline]
[Order article via Infotrieve]
|
| 35.
|
Berven, L. A.,
Hughes, B. P.,
and Barritt, G. J.
(1994)
Biochem. J.
299,
399-407[Medline]
[Order article via Infotrieve]
|
| 36.
|
Yang, L. J.,
Baffy, G.,
Rhee, S. G.,
Manning, D.,
Hansen, C. A.,
and Williamson, J. R.
(1991)
J. Biol. Chem.
266,
22451-22458[Abstract/Free Full Text]
|
| 37.
|
Bakowski, D.,
Glitsch, M. D.,
and Parekh, A. B.
(2001)
J. Physiol. (Lond.)
532,
55-71[Abstract/Free Full Text]
|
| 38.
|
Berven, L. A.,
Crouch, M. F.,
Katsis, F.,
Kemp, B. E.,
Harland, L. M.,
and Barritt, G. J.
(1995)
J. Biol. Chem.
270,
25893-25897[Abstract/Free Full Text]
|
| 39.
|
Tong, L. J.,
Dong, L. W.,
and Liu, M. S.
(1998)
Mol. Cell. Biochem.
189,
55-61[CrossRef][Medline]
[Order article via Infotrieve]
|
| 40.
|
Leslie, C. C.
(1997)
J. Biol. Chem.
272,
16709-16712[Free Full Text]
|
| 41.
|
Smith, W. L.,
Garavito, R. M.,
and DeWitt, D. L.
(1996)
J. Biol. Chem.
271,
33157-33160[Free Full Text]
|
| 42.
|
Evans, M. G.,
and Marty, A.
(1986)
J. Physiol. (Lond.)
378,
437-460[Abstract/Free Full Text]
|
| 43.
|
Arreola, J.,
Melvin, J. E.,
and Begenisich, T.
(1996)
J. Gen. Physiol.
108,
35-47[Abstract/Free Full Text]
|
| 44.
|
Wakui, M.,
Kase, H.,
and Petersen, O. H.
(1991)
J. Membr. Biol.
124,
179-187[CrossRef][Medline]
[Order article via Infotrieve]
|
| 45.
|
Randriamampita, C.,
Chanson, M.,
and Trautmann, A.
(1988)
Pflugers Arch.
411,
53-57 |